Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on MoonLake Immunotherapeutics (NASDAQ:MLTX) while keeping ...

In a report released on May 27, Jason Butler from Citizens JMP reiterated a Buy rating on Zevra Therapeutics, Inc.

On May 23, analyst Joseph Quatrochi from Wells Fargo maintained a Buy rating on Applied Materials, Inc. (NASDAQ:AMAT) while keeping the price target of $200. The reiteration comes after the company ...

We recently published a list of Was Jim Cramer Right About These 11 Stocks? In this article, we are going to take a look at where Sarepta Therapeutics Inc. (NASDAQ:SRPT) stands against other stocks ...

Trump pulls surgeon general nominee Janette Nesheiwat after questions about her medical education Here's the Average Social Security Benefit at Ages 62, 67, and 70 U.S. Issues 'Serious' Travel ...

We recently published a list of 15 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where The ...

We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Lexicon Pharmaceuticals, Inc.

The Global Microscopy Market is expected to witness a CAGR of ~5-6% in the next 5 years. Prospects of microscopes in ...

Two co-founders of 100X.VC, who left the early-stage sector-agnostic venture capital investment firm late last year, are now in the process of setting up their own VC firm, VCCircle has learned. The ...

That's why more investors are switching to BexBack - a fast-growing, no-KYC futures trading platform offering up to 100x leverage, a 100% deposit bonus, and a $50 welcome bonus for new users. Whether ...

MicroStrategy (Nasdaq: MSTR), rebranded to Strategy, founder Michael Saylor is well-known for his bullish outlook on Bitcoin. In a recent interview, he shared how even an average investor can ...